In addition, less than 1 percent of plant mutations were chosen for further research, and less than 1 percent of this group were found suitable for commercial use.
Pealegi valiti edasisteks uuringuteks välja alla 1 protsendi taimemutatsioonidest, kusjuures leiti, et sellest rühmast osutus äriliseks rakendamiseks kõlbavaks vähem kui 1 protsenti.